| Literature DB >> 26843862 |
Min Yang1, Jun Liu1, Jiong Xu1, Tiange Sun1, Li Sheng1, Zaoping Chen1, Fang Wang1, Xinmei Huang1, Yueyue Wu1, Jianfeng Mao1, Rui Zhang1.
Abstract
Background. This study investigated an association between systemic absolute neutrophil count (ANC) and albuminuria in elderly Chinese people. Methods. A cross-sectional study was conducted on 2265 participants attending a routine medical examination in Minhang District as part of a Platform of Chronic Disease program. Their drug history, waist circumference, height, blood pressure, fasting blood glucose, ANC, and urine albumin levels were recorded. This study conformed to the requirements of the STROBE statement. Results. Of the 2265 subjects, 1254 (55.4%) were diabetic and 641 (28.3%) had albuminuria. The mean ANC of patients with diabetes comorbid with macroalbuminuria was significantly higher than that of both the nondiabetic patients and patients with diabetes with lower levels of albuminuria; the latter 2 groups had statistically similar ANC. ANC significantly and positively correlated with levels of urine albumin. Based on multivariate analysis, with each 10(9)/L increase in ANC, the increase in rates of macroalbuminuria was significant but not in rates of albuminuria positivity. Based on areas under the receiver operating characteristic curve, ANC was the strongest factor predicting macroalbuminuria. Conclusions. Elevated ANC was associated with macroalbuminuria in diabetes, indicating that neutrophil-mediated inflammation may be involved in the exacerbation of albuminuria.Entities:
Year: 2015 PMID: 26843862 PMCID: PMC4710918 DOI: 10.1155/2015/348757
Source DB: PubMed Journal: Int J Endocrinol ISSN: 1687-8337 Impact factor: 3.257
Demographic and clinical data of patients.
| Diabetes | Albuminuria | |||||
|---|---|---|---|---|---|---|
| Diabetic | Nondiabetic |
| UA+ | UA− |
| |
| Subjects, | 1254 | 1011 | 641 | 1624 | ||
| Mean age, y | 71 (65–76) | 70 (65–75) | 0.021 | 70 (65–75) | 70 (65–75) | 0.0028 |
| Gender, male/female | 721/932 | 566/784 | NS | 266/375 | 717/906 | NS |
| BMI, kg/m2 | 23.7 (21.4–26.0) | 23.9 (21.6–26.3) | NS | 24.0 (21.8–26.5) | 23.6 (21.2–25.8) | 0.0012 |
|
| ||||||
| Waist-hip ratio | 0.88 (0.84–0.91) | 0.88 (0.84–0.91) | NS | 0.88 (0.84–0.91) | 0.87 (0.84–0.90) | 0.0002 |
| SBP, mmHg | 132 (127–147) | 130 (125–142) | 0.0066 | 133 (128–148) | 130 (124–140) | <0.0001 |
| DBP, mmHg | 80 (75–83) | 80 (76–83) | NS | 80 (76–84) | 80 (74–81) | 0.0019 |
| Hypertension | 774 (1254) | 568 (1011) | 0.0045 | 384 (641) | 924 (1624) | NS |
|
| ||||||
| ACE inhibitor | 73 (1254) | 39 (1011) | 0.0007 | 31 (641) | 60 (1624) | NS |
| ARB | 197 (1254) | 128 (1011) | 0.0218 | 91 (641) | 222 (1624) | NS |
| Total cholesterol, mmol/L | 5.8 (5.0–6.5) | 5.8 (5.1–6.5) | NS | 5.8 (5.0–6.5) | 5.8 (5.1–6.5) | NS |
| Triglycerides, mmol/L | 1.8 (1.3–2.4) | 1.8 (1.3–2.4) | NS | 1.8 (1.3–2.4) | 1.7 (1.2–2.3) | NS |
|
| ||||||
| FBG, mmol/L | 5.7 (5.3–7.4) | 5.8 (5.5–6.2) | <0.0001 | 5.9 (5.4–6.6) | 5.8 (5.4–6.4) | NS |
| Two-hour glucose, mmol/L | 8.4 (6.8–12.9) | 8.5 (7.9–9.3) | 0.0032 | 8.5 (7.2–10.7) | 8.4 (7.1–10.3) | NS |
| SCr, | 69 (58–90) | 70 (60–81) | NS | 70 (59–2) | 68.5 (60–78) | 0.0038 |
| ALT, U/L | 21 (16–27) | 21 (17–28) | NS | 21 (16–28) | 21 (16–27) | NS |
|
| ||||||
| WBC, 109/L | 6.0 (5.1–7.0) | 5.9 (5.1–6.8) | 0.0138 | 6.0 (5.1–7.0) | 5.8 (5.0–6.8) | 0.0131 |
| ANC, 109/L | 3.5 (2.8–4.3) | 3.3 (2.8–4.3) | 0.0001 | 3.4 (2.8–4.2) | 3.3 (2.7–4.0) | <0.0001 |
| ANC/WBC, % | 57.6 (50.8–63.9) | 56.3 (49.8–62.3) | 0.0007 | 58.0 (51.9–64.0) | 56.2 (50.8–62.3) | 0.0006 |
| ACR, mg/g | 6.4 (0–20.8) | 3.2 (0–12.6) | 0.0002 | 9.2 (27–19.2) | 0 | <0.0001 |
Data are presented as median and 25th–75th percentile, unless otherwise noted.
ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blocker; NS, not significant.
Figure 1ANC and ANC/WBC ratios of groups stratified by UA severity. The ANC value and ANC/WBC ratio of the group with diabetes and macroalbuminuria were much higher than those of the other 4 groups. A: compared with nondiabetes group, P < 0.05. B: compared with diabetes without UA, P < 0.05. C: compared with diabetes with low-level UA, P < 0.05. D: compared with diabetes with macroalbuminuria, P < 0.05.
ANC quintiles in relation to the risk of macroalbuminuria and positive UA, OR (95% CI).
| ANC, 103/ | Macroalbuminuria | UA+
| |
|---|---|---|---|
| I | ≤2.6 | Referent level | Referent level |
| II | 2.6 to 3.2 | 0.996 (0.691–1.435) | 1.271 (0.963–1.677) |
| III | 3.2 to 3.7 | 1.458 (1.012–2.099) | 1.333 (0.993–1.791) |
| IV | 3.7 to 4.4 | 1.351 (0.932–1.958) | 1.352 (1.000–1.827) |
| V | >4.4 | 2.311 (1.608–3.321) | 1.573 (1.148–2.154) |
P for trend ≤0.0001 and 0.0653 for macroalbuminuria and UA+, respectively, adjusted for age, BMI, gender, SBP, DBP, and SCr.
AUCs for predicting macroalbuminuria.
| AUC (95% CI) | Fold change |
| ||
|---|---|---|---|---|
| ANC, 103/ | 0.6001 (0.5689–0.6313) | — | — | |
| FBG, mmol/L | 0.5876 (0.5561–0.6191) | — | — | |
| SCr, | 0.5545 (0.5225–0.5869) | — | — | |
| SBP, mmHg | 0.5767 (0.5457–0.6077) | — | — | |
|
| ||||
| Model 1 | ANC × FBG | 0.6179 (0.5872–0.6486) | — | — |
| Model 2 | ANC × FBG × SBP | 0.6282 (0.6068–0.6676) | 1.67 | 0.5188 |
| Model 3 | ANC × FBG × SBP × SCr | 0.6372 (0.5978–0.6586) | 3.12 | 0.5338 |
Compared with Model 1.